ETPN2022: registration & abstract submission OPEN!

ETPN2022, the 17th annual event of the European Technology Platform on Nanomedicine will be organized with INL in Braga Portugal on June 20-23, 2022!

Largest in-person conference dedicated to Nanomedicine in Europe this year. Let’s bring our community back together again!

Submit your abstract until April 30. Early-bird registration fees until May, 7.

Learn more!

What is nanomedicine?

Nanomedicine is the application of nanotechnology to achieve innovation in healthcare. It uses the properties developed by a material at its nanometric scale 10-9 m which often differ in terms of physics, chemistry or biology from the same material at a bigger scale.

Moreover, the nanometric size is also the scale of many biological mechanisms in the human body allowing nanoparticles and nanomaterials to potentially cross natural barriers to access new sites of delivery and to interact with DNA or small proteins at different levels, in blood or within organs, tissues or cells.

Know more

ETPN strategic inputs

As a major pan-European industry-oriented initiative, the ETPN aims at strengthening Europe’s capabilities and competitiveness in the area of nanomedicine innovation. Since 2005 the ETPN published a number of strategic documents outlining the needs and roadmaps for nanomedicine research in Europe.

We have contributed to set up numerous European funded projects providing a first impression of the conditions for a suitable social and economic environment and the structural requirements for an efficient translation of R&D results into innovative nanomedicine.

Know more

ETPN support to innovation

Complementary to its strategic inputs as an ETP to shape and support public funding on the most promising areas of Nanomedicine, the ETPN has designed in 2014 unique technical infrastructures regrouped in a central instrument: the Nanomedicine Translation HUB.

These free of charge services support and accelerate the development of the best Nanomedicine projects from innovative design to clinical development.

Know more

Key reasons to become a member:

Meet new partners and end-users
Share your success stories
Benefit from unique advantages
Shape the future of Nanomedicine in europe
Promote and educate

Know more

Are you on the Nanomedicine map?

The NanoMed Map provides thorough insights into the nanomedicine community by showing all the actors of the ecosystem in Europe and beyond. It was initiated by NanoMed 2020, CSA project under FP7_Health.

See the map



Latest news

SFNano is launching a call for the SFNano PhD award 2022.

Jul 25, 2022

Dear ETPN members, dear colleagues, we are glad to share with you a nice opportunities for young researchers in Nanomedicine organized by the Société Française de Nanomédecine, SF Nano. This award will be rewarding a young PhD holder for his/her significant...

The ETPN joins the new Nanospresso-NL project for the production of nucleic acid nanomedicine at the bedside!

Mar 21, 2022

The project proposal NANOSPRESSO-NL will be funded by the Dutch Research Council with a 9M€ budget for the next five years. NANOSPRESSO-NL will develop a disruptive technology to make lipid nanoparticles for the delivery of RNA and DNA at the bedside, initially for orphan diseases. The ETPN will be participating in this great innovative Nanomedicine project, notably to optimize its communication and dissemination activities.

« Older Entries



Events agenda

Aug 22, 2022
Annual meeting 2022 of the British Society of Nanomedicine (Swansea)

Sep 05, 2022
RanT2022 – Raman Nanotehranostics conference at the University of Exeter (UK)

All Events »



Job offers

Jul 04, 2022
Postdoctoral researcher: “Synthesis of short and biocompatible peptide nanotubes for therapeutic applications” at CNRS in Strasbourg, France

May 26, 2022
Postdoctoral researcher – two positions in circular RNA therapeutics at UCC (Cork)

Apr 19, 2022
PhD position in Biomedicine at CIMUS – USC, Spain

Mar 31, 2022
Research Scientist within polymer chemistry and materials at SINTEF

Mar 07, 2022
Group Leader in 3D Bioprinting, Tissue Engineering and Regenerative Medicine at UPV/EHU, Spain.

Feb 28, 2022
RNA Therapeutics Research Scientist at OSE Immunotherapeutics (France)

All Offers »



Quick access

ETPN Intranet

Accessible to ETPN members

ETPN premium members

Translation Hub

Join the ETPN!

Click here to become a member

Subscribe to the ETPN newsletter